Back to Journals » Neuropsychiatric Disease and Treatment » Volume 2 » Issue 2

SJR OA
CiteScore
Impact Factor

Neuropsychiatric Disease and Treatment

ISSN: 1178-2021


       

Archive: Volume 2, 2006


Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder

Ranita Basu, Jaspreet S Brar

Neuropsychiatric Disease and Treatment 2006, 2:241-243

Published Date: 15 June 2006

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam

Adeeb Yacoub, Andrew Francis

Neuropsychiatric Disease and Treatment 2006, 2:235-240

Published Date: 15 June 2006

Cognitive impairment in elderly women: the relative importance of selected genes, lifestyle factors, and comorbidities

Henrik Berg Rasmussen, Yu Z Bagger, László B Tankó, Gerong Qin, Claus Christiansen

Neuropsychiatric Disease and Treatment 2006, 2:227-233

Published Date: 15 June 2006

Associations between the COMT Val/Met polymorphism, early life stress, and personality among healthy adults

Karin F Hoth, Robert H Paul, Leanne M Williams, Carol Dobson-Stone, Elizabeth Todd, Peter R Schofield, John Gunstad, Ronald A Cohen, Evian Gordon

Neuropsychiatric Disease and Treatment 2006, 2:219-225

Published Date: 15 June 2006

Understanding reported cognitive dysfunction in older adults with cardiovascular disease

John Gunstad, Ronald A Cohen, Robert H Paul, David F Tate, Karin F Hoth, Athena Poppas

Neuropsychiatric Disease and Treatment 2006, 2:213-218

Published Date: 15 June 2006

CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease

Aoife Hunt, Peter Schönknecht, Markus Henze, Pablo Toro, Uwe Haberkorn, Johannes Schröder

Neuropsychiatric Disease and Treatment 2006, 2:207-212

Published Date: 15 June 2006

Hormones and dementia – a comparative study of hormonal impairment in post-menopausal women, with and without dementia

Olívia Robusto-Leitao, H Ferreira

Neuropsychiatric Disease and Treatment 2006, 2:199-206

Published Date: 15 June 2006

Aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting

Luiz Dratcu, Patricia Olowu, Muzafar Hawramy, Charitomeni Konstantinidou

Neuropsychiatric Disease and Treatment 2006, 2:191-197

Published Date: 15 June 2006

Cognitive neuroscience of delusions in aging

Anna EM Holt, Martin L Albert

Neuropsychiatric Disease and Treatment 2006, 2:181-189

Published Date: 15 June 2006

“Getting physical”: the management of neuropsychiatric disorders using novel physical treatments

Gin S Malhi, Colleen Loo, Catherine M Cahill, Jim Lagopoulos, Philip Mitchell, Perminder Sachdev

Neuropsychiatric Disease and Treatment 2006, 2:165-179

Published Date: 15 June 2006

Restless legs syndrome: diagnosis and review of management options

Ruth Byrne, Smita Sinha, K Ray Chaudhuri

Neuropsychiatric Disease and Treatment 2006, 2:155-164

Published Date: 15 June 2006

Bipolar disorders: treatment options and patient satisfaction

Charles Bowden, Vivek Singh

Neuropsychiatric Disease and Treatment 2006, 2:149-153

Published Date: 15 June 2006

The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder

Emanuela Mundo, Elisabetta Cattaneo, Silvia Zanoni, A Carlo Altamura

Neuropsychiatric Disease and Treatment 2006, 2:139-148

Published Date: 15 June 2006

Risperidone in the treatment of bipolar mania

Martha Sajatovic, Subramoniam Madhusoodanan, Matthew A Fuller

Neuropsychiatric Disease and Treatment 2006, 2:127-138

Published Date: 15 June 2006

Memantine combined with an acetyl cholinesterase inhibitor – hope for the future?

Chris Fox, Ian D Maidment, Malaz Boustani, Cornelius Katona

Neuropsychiatric Disease and Treatment 2006, 2:121-125

Published Date: 15 June 2006

Editorial: Progress in the treatment of bipolar disorder ||FREE PAPER||

Allan Young

Neuropsychiatric Disease and Treatment 2006, 2:119-120

Published Date: 15 June 2006